Xintela AB publishes Annual Report 2023

Xintela AB (publ) announces that the company’s annual report for 2023 is published on the company’s website www.xintela.se and is attached to this announcement. Link to the annual report: https://www.xintela.se/en/report-archive Contacts Xintela AB (publ)Evy Lundgren-Åkerlund, CEOTel: +46 46 275 65 00Email: evy@xintela.seMedicon Village223 81 Lund, Swedenwww.xintela.se About Xintela Xintela develops medical products in stem cell […]

Xintela AB Year-end Report 2023

Summary of the interim reportThe “Company” or “Xintela” refers to Xintela AB (publ), corporate registration number 556780-3480. Fourth quarter 2023 for the groupIncome amounted to TSEK 78 (0).Loss before tax totalled TSEK 12,175 (loss: 23,384).Loss per share was SEK 0.03 (loss: 0.09). The year 2023 for the groupIncome amounted to TSEK 78 (0).Loss before and […]

Xintela AB Interim Report January – September 2023

Summary of the interim reportThe “Company” or “Xintela” refers to Xintela AB (publ), corporate registration number 556780-3480. Third quarter 2023 for the groupIncome amounted to TSEK 0 (0).Loss before tax totalled TSEK 11,953 (loss: 14,456).Loss per share was SEK 0.02 (loss: 0.11). First nine month 2023 for the groupIncome amounted to TSEK 0 (0).Loss before […]

Xintela AB Interim Report January – June 2023

Summary of the interim reportThe “Company” or “Xintela” refers to Xintela AB (publ), corporate registration number 556780-3480. Second quarter 2023 for the groupIncome amounted to TSEK 0 (0).Loss before and tax totalled TSEK 18,401 (loss: 18,942).Loss per share* was SEK 0.06 (loss: 0.21). First half year 2023 for the groupIncome amounted to TSEK 0 (0).Loss before […]

Xintela AB Interim Report January – March 2023

Summary of the interim reportThe “Company” or “Xintela” refers to Xintela AB (publ), corporate registration number 556780-3480. First quarter 2023 for the groupIncome amounted to TSEK 0 (0).Loss before and tax totalled TSEK 15,843 (loss: 16,383).Loss per share* was SEK 0.05 (loss: 0.18). First quarter 2023 for the parent companyIncome amounted to TSEK 0 (0).Loss before […]

Xintela AB publishes Annual Report 2022

Xintela AB (publ) announces that the Swedish version of the company’s Annual Report for 2022 is published on the company’s website, www.xintela.se. The English version will be published shortly. Link to the annual report:https://www.xintela.se/en/report-archive Contacts Xintela AB (publ)Evy Lundgren-Åkerlund, CEOTel: +46 46 275 65 00Email: evy@xintela.seMedicon Village223 81 Lund, Swedenwww.xintela.se About Xintela Xintela develops medical […]

Xintela Year-end report 2022

Summary of the year-end report. The “Company” or “Xintela” refers to Xintela AB (publ), corporate registration number 556780-3480. Third quarter 2022 for the group Fourth quarter 2022 for the groupIncome amounted to TSEK 0 (0).Loss before and tax totalled TSEK 23,384 (loss: 18,013).Loss per share* was SEK 0.09 (loss: 0.20). Twelve months 2022 for the groupIncome […]

Xintela AB Interim Report January – September 2022

Summary of the interim reportThe “Company” or “Xintela” refers to Xintela AB (publ), corporate registration number 556780-3480. Third quarter 2022 for the group» Income amounted to TSEK 0 (0)» Loss before and after tax totalled TSEK 14,456 (loss: 15,892)» Loss per share* was SEK 0.11 (loss: 0.20) First nine months 2022 for the group» Income […]

Xintela AB Interim Report January – June 2022

Summary of the interim reportThe “Company” or “Xintela” refers to Xintela AB (publ), corporate registration number 556780-3480. Second quarter 2022 for the group» Income amounted to TSEK 0 (0).» Loss before tax totalled TSEK 18,942 (loss: 15,020).» Loss per share was SEK 0.21 (loss: 0.17). First half year 2022 for the group» Income amounted to […]

Xintela AB Interim Report January – March 2022

Summary of the interim reportThe “Company” or “Xintela” refers to Xintela AB (publ), corporate registration number 556780-3480. First quarter 2022» Income amounted to TSEK 0 (0).» Loss before tax totalled TSEK 11,042 (loss: 9,047).» Loss per share* was SEK 0.12 (loss: 0.12).» At March 31, 2022, the equity/assets ratio** was -36 % (16). * Earnings/loss […]